Last $1.37 USD
Change Today -0.01 / -0.72%
Volume 221.7K
EKSO On Other Exchanges
As of 8:10 PM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

ekso bionics holdings inc (EKSO) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/24/14 - $8.22
52 Week Low
10/1/14 - $0.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

ekso bionics holdings inc (EKSO) Related Bloomberg News

View More Bloomberg News

ekso bionics holdings inc (EKSO) Related Businessweek News

No Related Businessweek News Found

ekso bionics holdings inc (EKSO) Details

Ekso Bionics Holdings, Inc. designs, develops, and commercializes exoskeletons or wearable robots, which host a variety of applications in medical, military, industrial, and consumer markets in North America and Europe. It offers Ekso, a bionic suit or wearable robot, which helps individuals with lower-extremity weakness; paralysis; hemiparesis due neurological disease; or injuries, such as spinal cord injuries, stroke, multiple sclerosis, and Guilain Barre syndrome to stand up and walk with a natural, fully weight bearing gait. The company’s Ekso is used primarily in a clinic or rehabilitation setting, under the supervision of a physical therapist, or in limited cases, as part of an IRB study with a trained lay spotter. The company was founded in 2005 and is based in Richmond, California. It has Ekso centers in the United States, Canada, Czech Republic, Denmark, England, Estonia, Finland, Germany, Italy, Norway, Poland, the Russian Federation, Spain, Sweden, Turkey, South Africa, and Mexico. As of October 31, 2012, Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital, PA.

60 Employees
Last Reported Date: 06/24/14
Founded in 2005

ekso bionics holdings inc (EKSO) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $137.8K
Co-Founder, Chief Technology Officer and Pres...
Total Annual Compensation: $151.9K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $144.8K
Chief Operating Officer
Total Annual Compensation: $165.9K
Compensation as of Fiscal Year 2013.

ekso bionics holdings inc (EKSO) Key Developments

Ekso Bionics Holdings, Inc. Announces Executive Changes

Ekso Bionics Holdings, Inc. announced the promotion of Thomas Looby to President and Chief Commercial Officer, effective immediately. Tom will be responsible for expanding global sales and marketing operations, including overseeing Ekso Bionics' clinical, customer service and regulatory divisions. Ekso Bionics also announced the hiring of Niel McCaffrey as VP of Engineering, Medical. Niel will be focused on advancing Ekso Bionics' medical engineering team and intellectual property library.

Boston Dynamics Selects Ekso Bionics Holdings, Inc to Execute DARPA Project

Ekso Bionics Holdings, Inc. announced that it was selected by Boston Dynamics, now part of Google, to continue developing technologies for Defense Advanced Research Projects Agency's (DARPA's) Warrior Web Task A project. Ekso received a subcontract from Google for the project, in which Ekso Bionics will retain rights to its proprietary intellectual property. This extends the collaboration previously created from the selection of Ekso Bionics by Boston Dynamics in support of this important program in 2013 and brings the total amount of the grants awarded in the last twelve months to Ekso Labs(TM), the engineering services division of Ekso Bionics, to $4.5 million of non-dilutive funding. Testing for the Warrior Web Task A project culminated last week with six soldiers marching through 84 miles of obstacle filled terrain, carrying large loads, weapon and helmet. There were no incidences of failure reported. This lightweight, wearable, low power, assistive technology will help advance the capabilities of current and future Ekso Bionics product offerings in medical, industrial, consumer and military markets. The Warrior Web program is aimed at developing technologies to prevent or reduce musculoskeletal injuries caused by taxing physical activity, which is typical with an active warfighter. The program's goal is to develop a lightweight, conformal under-suit that is transparent to the user (like a diver's wetsuit). It further seeks to develop a mix of core technologies critical to the realization of a Warrior Web capability. This effort examines five key Technology Areas: core injury mitigation technologies, comprehensive analytical representations, regenerative actuation, adaptive sensing and control, and suit human-to-wearer interface.

Ekso Bionics Holdings, Inc. and SoldierSocks Expand Partnership with Three-Year, 80-Unit Pledge

Ekso Bionics Holdings, Inc. announced that it has signed a Memorandum of Understanding with SoldierSocks. Over the next three years, SoldierSocks has established a goal of purchasing 80 Ekso GT(TM) robotic exoskeleton suits for VA Hospitals, organizations serving veterans, and eventually direct to veterans. This announcement represents an extension of Ekso Bionics'(TM) previous partnership with SoldierSocks, who earlier 2014 committed to purchasing ten suits, and expects to complete that commitment by year-end.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EKSO:US $1.37 USD -0.01

EKSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CYBERDYNE Inc ¥3,485 JPY +105.00
Parker-Hannifin Corp $127.03 USD +2.36
ReWalk Robotics Ltd $30.65 USD +0.21
Rex Bionics PLC 165.50 GBp 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation EKSO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 27.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 25.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EKSO BIONICS HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at